Carbonic anhydrase inhibitors vs inactive control
Cardiovascular mortality · adults with central sleep apnoea associated with heart failure
It is very uncertain whether carbonic anhydrase inhibitors changes cardiovascular mortality compared with inactive control (very low certainty).
1 finding from 1 review
- OR 0.21 [0.02, 2.48]1 study · 18 participantsVery low